Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Stopped early · Phase 1
Conditions studied: Prostate Cancer
In brief
RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill prostate tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic prostate cancer.
Key facts
- Study ID
- NCT00010127
- Run by
- Duke University
- People needed
- 3
- Starts
- 2000-11-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2013-03-21
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.